Mission
Our goal is to cure cancer, with minimal or no side effects. Virtually all cancer treatments are toxic to both cancer cells and normal cells. The result is the treatment becomes a race between killing the cancer and killing the patient.
This new method involves using the immune systems, of animals that are of a different species than the animal that has cancer, to create antibodies against the cancer cells. The antibodies are used to locate unique cancer-specific sites on the cancer cells. These sites are not possessed by the normal cells of the animal that has cancer. The cancer-specific sites are then used as a target for agents that will kill the cancer cells without affecting the normal cells, resulting in minimal or no side effects.
In our proof-of-concept experiments we used human breast cancer cells. The method is applicable to any cancer.